Tim Smit
- European Investment Bank
- Communication Department
- 98-100, boulevard Konrad Adenauer
- L-2950 Luxembourg
- Luxembourg
The European Investment Bank (EIB) will lend €120 million to Danish hearing-aid innovator Demant A/S in support of its investments in research, development and innovation (RDI) for new devices that can improve the quality of life for people suffering from hearing loss. Demant will use the EIB financing for its ongoing development of next generation hearing aids, building on its previous RDI programmes that were also co-financed by the EIB. This is the fifth such EIB financing to Demant since 2015, with the EIB having made available €455 million to advance the company’s innovation programmes.
Signature is first Linked Risk Sharing agreement in Denmark, aimed at increasing risk appetite among banks and improving access to finance for Danish businesses.
Danish biotech SNIPR Biome will get up to €20 venture debt from the European Investment Bank (EIB) to step up Europe’s fight against antimicrobial resistance to medicines. The company will use the EIB credit to develop new medicines for infections where existing antibiotics are no longer effective.